Your browser is no longer supported. Please, upgrade your browser.
OPK OPKO Health, Inc. daily Stock Chart
OPK [NASD]
OPKO Health, Inc.
Index- P/E- EPS (ttm)-0.48 Insider Own5.00% Shs Outstand652.82M Perf Week-3.11%
Market Cap1.02B Forward P/E- EPS next Y-0.27 Insider Trans17.92% Shs Float401.78M Perf Month9.09%
Income-278.60M PEG- EPS next Q-0.08 Inst Own22.60% Short Float18.51% Perf Quarter-31.28%
Sales899.40M P/S1.13 EPS this Y50.20% Inst Trans-4.07% Short Ratio14.15 Perf Half Y-22.00%
Book/sh2.80 P/B0.56 EPS next Y37.20% ROA-11.30% Target Price4.13 Perf Year-54.25%
Cash/sh0.10 P/C15.74 EPS next 5Y12.00% ROE-16.10% 52W Range1.33 - 3.93 Perf YTD-48.17%
Dividend- P/FCF- EPS past 5Y3.40% ROI-6.60% 52W High-60.36% Beta2.24
Dividend %- Quick Ratio0.90 Sales past 5Y59.30% Gross Margin35.50% 52W Low17.29% ATR0.07
Employees5690 Current Ratio1.10 Sales Q/Q-8.40% Oper. Margin-28.00% RSI (14)43.58 Volatility4.69% 4.63%
OptionableYes Debt/Eq0.17 EPS Q/Q-114.10% Profit Margin-31.00% Rel Volume0.76 Prev Close1.53
ShortableYes LT Debt/Eq0.16 EarningsNov 05 AMC Payout- Avg Volume5.26M Price1.56
Recom1.50 SMA20-0.38% SMA50-7.87% SMA200-24.03% Volume3,972,647 Change1.96%
Nov-25-19Initiated Piper Jaffray Overweight $2.50
Mar-02-18Downgrade JP Morgan Neutral → Underweight
Sep-14-17Downgrade JP Morgan Overweight → Neutral
Jun-21-16Reiterated Standpoint Research Buy $16 → $18
Jun-03-16Initiated Standpoint Research Buy $16
Mar-31-16Reiterated Barrington Research Outperform $17 → $16
Oct-16-15Initiated JP Morgan Overweight $14
Sep-11-15Downgrade Jefferies Buy → Hold
Mar-03-15Downgrade Oppenheimer Outperform → Perform
May-12-14Reiterated Oppenheimer Outperform $13 → $12
Mar-14-14Initiated Oppenheimer Outperform $13
Nov-13-13Reiterated Ladenburg Thalmann Buy $10 → $14.50
May-30-13Reiterated Ladenburg Thalmann Buy $8.50 → $10
Oct-22-12Initiated Barrington Research Outperform $6
Dec-01-11Reiterated Ladenburg Thalmann Buy $6 → $8.50
Jul-14-11Initiated Ladenburg Thalmann Buy $6
Dec-13-19 12:52PM  Is Opko Health Inc. (OPK) Going to Burn These Hedge Funds? Insider Monkey
Dec-10-19 12:00PM  The OPKO Health (NASDAQ:OPK) Share Price Is Down 86% So Some Shareholders Are Rather Upset Simply Wall St.
Dec-09-19 10:49AM  Weekly CEO Buys Highlight GuruFocus.com
Dec-05-19 11:31AM  Why Is OPKO Health (OPK) Up 10.8% Since Last Earnings Report? Zacks
Nov-26-19 08:00AM  OPKO Health to Participate in the 31st Annual Piper Jaffray Healthcare Conference GlobeNewswire
Nov-22-19 09:26AM  Here's Why You Should Hold on to OPKO Health (OPK) Stock Now Zacks
Nov-15-19 08:00AM  Novitas Issues Final Local Coverage Determination for the 4Kscore® Test GlobeNewswire
Nov-12-19 11:11PM  Edited Transcript of OPK earnings conference call or presentation 5-Nov-19 9:30pm GMT Thomson Reuters StreetEvents
Nov-11-19 10:56AM  Weekly CEO Buys Highlight GuruFocus.com
Nov-08-19 01:02PM  Insiders Roundup: Crocs, OPKO Health GuruFocus.com
Nov-07-19 08:16AM  OPKO Health (OPK) Q3 Earnings Miss Estimates, Revenues Beat Zacks
Nov-05-19 07:05PM  OPKO Health (OPK) Reports Q3 Loss, Tops Revenue Estimates Zacks
04:05PM  OPKO Health Reports 2019 Third Quarter Business Highlights and Financial Results GlobeNewswire
Nov-04-19 10:37AM  Weekly CEO Buys Highlight GuruFocus.com
08:00AM  BioReference Laboratories and GeneDx to Present at NSGC 2019, Demonstrating Commitment to Genetic Counselors and the Research of Rare Genetic Disorders GlobeNewswire
Nov-01-19 11:51AM  Largest Insider Trades of the Week GuruFocus.com +5.63%
10:30AM  Earnings Preview: OPKO Health (OPK) Q3 Earnings Expected to Decline Zacks
08:00AM  OPKO Health to Report Third Quarter 2019 Financial Results on November 5, 2019 GlobeNewswire
Oct-28-19 12:06PM  Weekly CEO Buys Highlight GuruFocus.com +5.56%
11:23AM  OPKO Health Enters Oversold Territory Zacks
Oct-26-19 12:44PM  Here is What Hedge Funds Think About Opko Health Inc. (OPK) Insider Monkey
Oct-24-19 06:57PM  OPKO Health, Inc. Announces Pricing of its Offering of Common Stock GlobeNewswire -14.21%
10:38AM  Implied Volatility Surging for OPKO Health (OPK) Stock Options Zacks
Oct-22-19 04:05PM  OPKO Health, Inc. Announces Proposed Offering of Common Stock GlobeNewswire
Oct-21-19 08:21AM  Opko and Pfizer announce positive results in late-stage trial of human growth hormone treatment MarketWatch
08:00AM  OPKO and Pfizer Announce Positive Phase 3 Top-Line Results for Somatrogon, an Investigational Long-Acting Human Growth Hormone to Treat Children with Growth Hormone Deficiency GlobeNewswire
Oct-09-19 08:14AM  What Kind Of Shareholders Own OPKO Health, Inc. (NASDAQ:OPK)? Simply Wall St.
Sep-19-19 12:13PM  Is the Options Market Predicting a Spike in OPKO Health (OPK) Stock? Zacks
Sep-17-19 10:00AM  Here's Why You Should Retain OPKO Health (OPK) Stock For Now Zacks
Sep-06-19 09:31AM  Why Is OPKO Health (OPK) Down 2.6% Since Last Earnings Report? Zacks
Sep-03-19 11:15AM  Is OPKO Health (NASDAQ:OPK) A Risky Investment? Simply Wall St.
Aug-30-19 01:49PM  Edited Transcript of OPK earnings conference call or presentation 7-Aug-19 8:30pm GMT Thomson Reuters StreetEvents
Aug-29-19 09:24AM  OPKO Completes Pivotal Phase 3 Study for Somatrogon (hGH-CTP), an Investigational Long-Acting Growth Hormone Being Studied for the Treatment of Children With Growth Hormone Deficiency GlobeNewswire
Aug-11-19 04:02PM  Analysts Suggest 3 Falling Knives GuruFocus.com
Aug-08-19 08:59AM  OPKO Health (OPK) Q2 Earnings and Revenues Beat Estimates Zacks
03:25AM  Opko Health (OPK) Q2 2019 Earnings Call Transcript Motley Fool
Aug-07-19 08:45PM  OPKO Health (OPK) Reports Q2 Loss, Tops Revenue Estimates Zacks
04:05PM  OPKO Health Reports 2019 Second Quarter Business Highlights and Financial Results GlobeNewswire
08:23AM  A Preview Of Opko Health's Q2 Earnings Benzinga
Aug-01-19 08:00AM  OPKO Health to Report Second Quarter 2019 Financial Results on August 7, 2019 GlobeNewswire
08:00AM  BIOREFERENCE LABORATORIES SELECTED AS PREFERRED LABORATORY PROVIDER BY THE IPA ASSOCIATION OF AMERICA GlobeNewswire
Jul-30-19 10:38AM  Earnings Preview: OPKO Health (OPK) Q2 Earnings Expected to Decline Zacks
Jul-29-19 07:14AM  Is OPKO Health, Inc.'s (NASDAQ:OPK) CEO Pay Fair? Simply Wall St.
Jul-22-19 12:10AM  Weekly CEO Buys Highlight GuruFocus.com
Jul-14-19 11:34AM  Weekly Top Insider Buys Highlight for the Week of July 12 GuruFocus.com
Jul-05-19 08:39AM  Do Options Traders Know Something About OPKO Health (OPK) Stock We Don't? Zacks
Jul-01-19 09:29AM  OPKO Healths BioReference Laboratories Forms a Strategic Collaboration With SOMOS to Improve Health Outcomes of Underserved New Yorkers GlobeNewswire
08:00AM  BioReference Laboratories Forms a Strategic Collaboration with SOMOS to Improve Health Outcomes of Underserved New Yorkers GlobeNewswire
Jun-28-19 06:01PM  Heres What Hedge Funds Think About Opko Health Inc. (OPK) Insider Monkey +9.91%
05:00PM  Why OPKO Health Stock Jumped Today Motley Fool
08:00AM  Novitas Issues Proposed Local Coverage Determination for the 4Kscore® Test GlobeNewswire
Jun-20-19 08:00AM  OPKO Health Submits De Novo Request to the U.S. FDA for the 4Kscore® Test GlobeNewswire
Jun-18-19 02:50PM  South Florida businessman accused of $27M penny stock fraud agrees to proposed judgment American City Business Journals
Jun-14-19 10:04AM  Edited Transcript of OPK earnings conference call or presentation 7-May-19 8:30pm GMT Thomson Reuters StreetEvents
Jun-07-19 07:00AM  BioReference Laboratories Supports Man Cave Health During National Mens Health Month GlobeNewswire
Jun-06-19 09:31AM  Why Is OPKO Health (OPK) Down 6.7% Since Last Earnings Report? Zacks
Jun-01-19 11:37AM  The Week Ahead In Biotech: ASCO Presentations Pick Up The Pace Benzinga
May-30-19 01:57PM  When Will OPKO Health, Inc. (NASDAQ:OPK) Turn A Profit? Simply Wall St.
May-21-19 11:41AM  Weekly CEO Buys Highlight GuruFocus.com +5.53%
May-17-19 08:30AM  Aerobic Vaginitis (AV) Testing Now Available At BioReference Laboratories GlobeNewswire
May-15-19 12:15PM  Why $2.7M In Opko Put Buying May Not Be As Bearish As It Seems Benzinga
May-12-19 06:52PM  Notable Insider Buys This Past Week: Annaly Capital, MGM and More Benzinga
May-10-19 08:54AM  Do Options Traders Know Something About OPKO Health (OPK) Stock We Don't? Zacks
May-09-19 08:39AM  OPKO Health (OPK) Reports Loss in Q1, Misses Revenue Estimates Zacks
07:56AM  The Daily Biotech Pulse: Novartis Goes Shopping, Mixed Trial Results For Provention Bio, 4 Stocks To Debut Benzinga
May-08-19 03:35PM  Why Opko Health Stock Sank Today Motley Fool -11.44%
07:53AM  The Daily Biotech Pulse: Daiichi's Positive Breast Cancer Trial, Supernus Slumps, Axovant Reverse Split Benzinga
06:42AM  Bet on Top Stocks With Rising P/E to Enjoy Solid Gains Zacks
05:23AM  Opko Health (OPK) Q1 2019 Earnings Call Transcript Motley Fool
May-07-19 06:35PM  OPKO Health (OPK) Reports Q1 Loss, Misses Revenue Estimates Zacks -5.22%
05:32PM  OPKO Health: 1Q Earnings Snapshot Associated Press
04:20PM  OPKO Health Reports 2019 First Quarter Business Highlights and Financial Results GlobeNewswire
May-02-19 05:05PM  BioReference Laboratories to Present at ACOG 2019, Demonstrating Commitment to the Research of Hereditary Conditions GlobeNewswire
May-01-19 03:50PM  How Does OPKO Health, Inc. (NASDAQ:OPK) Affect Your Portfolio Volatility? Simply Wall St.
12:14PM  Is Opko Health Inc. (OPK) A Good Stock To Buy? Insider Monkey
Apr-30-19 08:00AM  OPKO Health to Report First Quarter 2019 Financial Results on May 7, 2019 GlobeNewswire
Apr-29-19 12:57PM  Weekly CEO Buys Highlight GuruFocus.com
Apr-22-19 01:28PM  Weekly CEO Buys Highlight GuruFocus.com
Apr-20-19 10:36PM  Stocks That Fell to 3-Year Lows in the Week of April 19 GuruFocus.com
Apr-17-19 11:32AM  BioReference Laboratories Recognized by Forbes as Best Large Employer of 2019 GlobeNewswire
Apr-15-19 06:46PM  Weekly CEO Buys Highlight GuruFocus.com
Apr-14-19 12:11PM  Weekly Top Insider Buys Highlight for the Week of April 12 GuruFocus.com
Apr-12-19 08:00AM  OPKO Reports Additional Oxyntomodulin, OPK-88003, Results From Phase 2 Diabetes and Obesity Trial GlobeNewswire
Apr-07-19 10:45PM  Weekly CEO Buys Highlight GuruFocus.com
Apr-01-19 10:51AM  Read This Before Selling OPKO Health, Inc. (NASDAQ:OPK) Shares Simply Wall St.
Mar-21-19 08:00AM  OPKO Announces Positive Topline Results In Phase 2 Diabetes And Obesity Trial GlobeNewswire +10.57%
Mar-06-19 12:15PM  Edited Transcript of OPK earnings conference call or presentation 27-Feb-19 9:30pm GMT Thomson Reuters StreetEvents
Mar-04-19 09:10AM  OPKO Health (OPK) Reports Loss in Q4, Misses on Revenues Zacks
Mar-01-19 09:48PM  OPKO Health Inc (OPK) Files 10-K for the Fiscal Year Ended on December 31, 2018 GuruFocus.com +7.45%
Feb-28-19 03:49PM  Who OPKO Health Is Tanking Today Motley Fool -8.27%
10:00AM  Watch These Four Healthcare Stocks Set The Pace on Thursday ACCESSWIRE
Feb-27-19 11:51PM  Opko Health Inc (OPK) Q4 2018 Earnings Conference Call Transcript Motley Fool
04:05PM  OPKO Health Reports 2018 Fourth Quarter Business Highlights and Financial Results GlobeNewswire
Feb-26-19 08:00AM  OPKO Health to Announce Fourth Quarter 2018 Financial Results on February 27, 2019 GlobeNewswire
Feb-13-19 08:30AM  Research Report Identifies Cognizant Technology Solutions, OPKO Health, MedEquities Realty Trust, AXT, Red Robin Gourmet Burgers, and Dorian LPG with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
Feb-05-19 04:33PM  Why Glu Mobile, Opko Health, and Church & Dwight Slumped Today Motley Fool -15.63%
12:07PM  Why Opko Health Is Tanking Today Motley Fool
08:30AM  OPKO Health, Inc. Announces the Pricing of its Offering of Convertible Senior Notes GlobeNewswire
07:47AM  The Daily Biotech Pulse: Gilead Earnings, Codexis Sings Pact With Merck, Eli Lilly Reports Positive Trial Results Benzinga
12:30AM  Johnson Fistel, LLP Announces Investigations of AbbVie Inc., Macquarie Infrastructure Corporation, OPKO Health, Inc. and Uxin Limited; Investors Encouraged to Contact Firm PR Newswire
OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories, a clinical laboratory that offers laboratory testing services. The Bio-Reference Laboratories also provides core genetic testing and leverage products, such as the 4Kscore prostate cancer test and the Claros 1 in-office immunoassay platform. The company's Pharmaceutical segment offers Rayaldee, a treatment for secondary hyperparathyroidism in adults with stage 3 or 4 chronic kidney disease, and vitamin D insufficiency; OPK88004, a selective androgen receptor modulator for benign prostatic hyperplasia, and other urologic and metabolic conditions; and OPK88003, a once or twice weekly oxyntomodulin that is in Phase II trials for type 2 diabetes and obesity. It is also developing hGH-CTP, a once-weekly human growth hormone injection in Phase III clinical trial in partnership with Pfizer, Inc.; VARUBI for chemotherapy-induced nausea and vomiting; and Factor VIIa drug for hemophilia. In addition, this segment develops and produces specialty active pharmaceutical ingredients; and discovers drugs for the treatment of cancer, heart disease, metabolic disorders, and a range of genetic anomalies. Further, it develops, manufactures, markets, and sells pharmaceutical, nutraceutical, and veterinary products; commercializes food supplements and over the counter products; manufactures and sells products primarily in the generics market; and imports, markets, distributes, and sells pharmaceutical products in a range of indications, including cardiovascular products, vaccines, antibiotics, gastro- intestinal products, hormones, and others. Additionally, the company operates pharmaceutical platforms in Ireland, Chile, Spain, and Mexico. OPKO Health, Inc. was incorporated in 1991 and is headquartered in Miami, Florida.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
FROST PHILLIP MD ET ALCEO & ChairmanDec 11Buy1.50100,000150,172168,244,729Dec 12 06:01 AM
FROST PHILLIP MD ET ALCEO & ChairmanDec 09Buy1.5950,00079,500168,144,729Dec 10 06:04 AM
FROST PHILLIP MD ET ALCEO & ChairmanDec 05Buy1.6050,00080,000168,094,729Dec 06 06:11 AM
FROST PHILLIP MD ET ALCEO & ChairmanDec 03Buy1.6010,28616,458168,044,729Dec 04 06:38 AM
FROST PHILLIP MD ET ALCEO & ChairmanDec 02Buy1.5650,00077,755168,034,443Dec 03 07:09 AM
FROST PHILLIP MD ET ALCEO & ChairmanNov 26Buy1.55100,000154,500167,984,443Nov 27 06:45 AM
FROST PHILLIP MD ET ALCEO & ChairmanNov 19Buy1.47100,000146,651167,884,443Nov 20 06:55 AM
FROST PHILLIP MD ET ALCEO & ChairmanNov 18Buy1.48100,000147,925167,784,443Nov 19 06:22 AM
FROST PHILLIP MD ET ALCEO & ChairmanNov 13Buy1.4250,00071,191167,684,443Nov 14 07:08 AM
FROST PHILLIP MD ET ALCEO & ChairmanNov 12Buy1.44200,000288,124167,634,443Nov 13 06:04 AM
FROST PHILLIP MD ET ALCEO & ChairmanNov 08Buy1.4850,00074,058167,434,443Nov 12 06:01 AM
FROST PHILLIP MD ET ALCEO & ChairmanNov 06Buy1.49350,000520,503167,384,443Nov 07 06:06 AM
FROST PHILLIP MD ET ALCEO & ChairmanOct 31Buy1.4350,00071,250167,034,443Nov 01 06:03 AM
FROST PHILLIP MD ET ALCEO & ChairmanOct 30Buy1.44200,000288,533166,984,443Oct 31 06:04 AM
FROST PHILLIP MD ET ALCEO & ChairmanOct 29Buy1.47200,000294,132166,784,443Oct 30 07:16 AM
PFENNIGER RICHARD C JRDirectorOct 25Buy1.4525,00036,243275,000Oct 25 04:11 PM
Rubin Steven DExecutive VP-AdministrationOct 25Buy1.5015,00022,5005,744,147Oct 25 02:46 PM
FROST PHILLIP MD ET ALCEO & ChairmanOct 25Buy1.502,000,0003,000,000166,234,443Oct 25 02:13 PM
HSIAO JANE PH DVice Chairman & CTOOct 25Buy1.50400,000600,0005,127,404Oct 25 02:10 PM
FROST PHILLIP MD ET ALCEO & ChairmanOct 25Buy1.40350,000491,121166,584,443Oct 28 06:04 AM
FROST PHILLIP MD ET ALCEO & ChairmanJul 16Buy2.1250,000105,98130,127,177Jul 17 07:14 AM
FROST PHILLIP MD ET ALCEO & ChairmanJul 12Buy2.1650,000107,78830,077,177Jul 15 06:55 AM
FROST PHILLIP MD ET ALCEO & ChairmanJul 08Buy2.23100,000222,83130,027,177Jul 09 06:30 AM
FROST PHILLIP MD ET ALCEO & ChairmanJul 02Buy2.4250,000120,87529,927,177Jul 03 01:06 PM
FROST PHILLIP MD ET ALCEO & ChairmanJun 25Buy2.01100,000200,64029,877,177Jun 26 06:43 AM
FROST PHILLIP MD ET ALCEO & ChairmanJun 20Buy2.0450,000102,12729,777,177Jun 21 07:10 AM
FROST PHILLIP MD ET ALCEO & ChairmanJun 19Buy2.0125,00050,13429,727,177Jun 20 06:28 AM
FROST PHILLIP MD ET ALCEO & ChairmanJun 18Buy2.0250,000100,95029,702,177Jun 19 06:08 AM
FROST PHILLIP MD ET ALCEO & ChairmanJun 14Buy1.9170,000133,86429,652,177Jun 17 06:46 AM
FROST PHILLIP MD ET ALCEO & ChairmanJun 13Buy1.9250,00096,20129,582,177Jun 14 06:09 AM
FROST PHILLIP MD ET ALCEO & ChairmanJun 12Buy1.8315,00027,37529,532,177Jun 13 07:32 AM
FROST PHILLIP MD ET ALCEO & ChairmanJun 11Buy1.8750,00093,25029,517,177Jun 12 06:57 AM
FROST PHILLIP MD ET ALCEO & ChairmanJun 07Buy1.8750,00093,58229,467,177Jun 10 06:10 AM
FROST PHILLIP MD ET ALCEO & ChairmanJun 06Buy1.9225,00047,97429,417,177Jun 07 07:03 AM
FROST PHILLIP MD ET ALCEO & ChairmanJun 05Buy1.92150,000288,20129,392,177Jun 06 06:05 AM
FROST PHILLIP MD ET ALCEO & ChairmanMay 31Buy1.76100,000176,42129,242,177Jun 03 06:03 AM
FROST PHILLIP MD ET ALCEO & ChairmanMay 30Buy1.8650,00093,22129,142,177May 31 06:07 AM
FROST PHILLIP MD ET ALCEO & ChairmanMay 29Buy1.8470,000128,97029,092,177May 30 06:49 AM
FROST PHILLIP MD ET ALCEO & ChairmanMay 28Buy1.90200,000380,34229,022,177May 29 06:15 AM
Fishel Robert ScottDirectorMay 28Buy1.9250,00096,0004,120,728May 29 06:10 AM
FROST PHILLIP MD ET ALCEO & ChairmanMay 23Buy1.92200,000383,80728,822,177May 24 06:53 AM
PFENNIGER RICHARD C JRDirectorMay 22Buy2.0530,00061,500250,000May 23 06:02 AM
FROST PHILLIP MD ET ALCEO & ChairmanMay 22Buy2.00125,000250,05628,622,177May 23 06:04 AM
FROST PHILLIP MD ET ALCEO & ChairmanMay 17Buy2.0850,000103,93128,497,177May 20 06:03 AM
FROST PHILLIP MD ET ALCEO & ChairmanMay 16Buy2.02100,000202,13928,447,177May 17 06:01 AM
FROST PHILLIP MD ET ALCEO & ChairmanMay 14Buy2.001,000,0001,995,02428,347,177May 15 06:04 AM
PFENNIGER RICHARD C JRDirectorMay 13Buy2.0550,000102,492220,000May 14 06:03 AM
FROST PHILLIP MD ET ALCEO & ChairmanMay 13Buy1.99200,000397,68727,347,177May 14 06:05 AM
FROST PHILLIP MD ET ALCEO & ChairmanMay 10Buy2.0870,000145,86127,147,177May 13 06:02 AM
FROST PHILLIP MD ET ALCEO & ChairmanMay 09Buy2.06285,000585,85027,077,177May 10 06:19 AM
HSIAO JANE PH DVice Chairman & CTOMay 09Buy2.0310,00020,29724,475,147May 10 06:17 AM
Rubin Steven DExecutive VP-AdministrationMay 09Buy2.1410,00021,4425,729,147May 10 06:16 AM
PAGANELLI JOHN ADirectorMay 09Buy2.0910,00020,888359,340May 10 06:11 AM
Logal AdamSr. Vice President, CFOMay 09Buy2.043,2506,630179,162May 10 06:13 AM
FROST PHILLIP MD ET ALCEO & ChairmanMay 08Buy2.11907,0001,914,57626,792,177May 09 06:15 AM
FROST PHILLIP MD ET ALCEO & ChairmanApr 22Buy2.3280,000185,61325,885,177Apr 23 06:13 AM
FROST PHILLIP MD ET ALCEO & ChairmanApr 17Buy2.4250,000120,95325,805,177Apr 18 07:17 AM
FROST PHILLIP MD ET ALCEO & ChairmanApr 16Buy2.5010,00024,99725,755,177Apr 17 07:09 AM
FROST PHILLIP MD ET ALCEO & ChairmanApr 15Buy2.4710,00024,65025,745,177Apr 16 06:56 AM
FROST PHILLIP MD ET ALCEO & ChairmanApr 12Buy2.5020,00049,99425,735,177Apr 15 06:09 AM
FROST PHILLIP MD ET ALCEO & ChairmanApr 11Buy2.4930,00074,56125,715,177Apr 12 06:02 AM
FROST PHILLIP MD ET ALCEO & ChairmanApr 10Buy2.5320,00050,60225,685,177Apr 11 07:13 AM
FROST PHILLIP MD ET ALCEO & ChairmanApr 09Buy2.5110,00025,09325,665,177Apr 10 06:10 AM
FROST PHILLIP MD ET ALCEO & ChairmanApr 04Buy2.5320,00050,62725,655,177Apr 05 07:20 AM
FROST PHILLIP MD ET ALCEO & ChairmanApr 02Buy2.5340,000101,18725,635,177Apr 03 06:03 AM
FROST PHILLIP MD ET ALCEO & ChairmanApr 01Buy2.5820,00051,56025,595,177Apr 02 06:04 AM
FROST PHILLIP MD ET ALCEO & ChairmanMar 27Buy2.49100,000248,64625,575,177Mar 28 07:19 AM
FROST PHILLIP MD ET ALCEO & ChairmanMar 18Buy2.4740,00098,98325,475,177Mar 19 06:52 AM
FROST PHILLIP MD ET ALCEO & ChairmanMar 14Buy2.45250,000612,91825,435,177Mar 15 09:23 AM
FROST PHILLIP MD ET ALCEO & ChairmanMar 06Buy2.5750,000128,62225,185,177Mar 07 09:45 AM
Rubin Steven DExecutive VP-AdministrationMar 06Buy2.568,00020,4525,719,147Mar 07 09:45 AM
FROST PHILLIP MD ET ALCEO & ChairmanFeb 28Buy2.48200,000495,94725,135,177Mar 01 07:38 AM
Rubin Steven DExecutive VP-AdministrationFeb 01Option Exercise0.6624,87716,4195,716,792Feb 05 04:33 PM
FROST PHILLIP MD ET ALCEO & ChairmanJan 17Buy3.6715,00055,03124,935,177Jan 18 06:55 AM
FROST PHILLIP MD ET ALCEO & ChairmanJan 16Buy3.7410,00037,36924,920,177Jan 17 06:52 AM
FROST PHILLIP MD ET ALCEO & ChairmanJan 14Buy3.7415,00056,05524,910,177Jan 15 06:16 AM
FROST PHILLIP MD ET ALCEO & ChairmanJan 11Buy3.8310,00038,32524,895,177Jan 14 06:51 AM
FROST PHILLIP MD ET ALCEO & ChairmanJan 10Buy3.6910,00036,90824,885,177Jan 11 06:59 AM
FROST PHILLIP MD ET ALCEO & ChairmanJan 09Buy3.6510,00036,50124,875,177Jan 10 07:11 AM
FROST PHILLIP MD ET ALCEO & ChairmanJan 08Buy3.6135,000126,37624,865,177Jan 09 07:11 AM
FROST PHILLIP MD ET ALCEO & ChairmanJan 07Buy3.5655,000195,92224,830,177Jan 08 07:32 AM
FROST PHILLIP MD ET ALCEO & ChairmanJan 04Buy3.4330,000102,91424,775,177Jan 07 07:11 AM
FROST PHILLIP MD ET ALCEO & ChairmanJan 03Buy3.2550,000162,69324,745,177Jan 04 06:55 AM
FROST PHILLIP MD ET ALCEO & ChairmanJan 02Buy3.2440,000129,71324,695,177Jan 03 07:51 AM
FROST PHILLIP MD ET ALCEO & ChairmanDec 31Buy2.97135,000401,06824,655,177Jan 02 08:44 AM
FROST PHILLIP MD ET ALCEO & ChairmanDec 28Buy3.13100,000312,89824,520,177Dec 31 07:07 AM